Sökning: id:"swepub:oai:DiVA.org:uu-105561" >
Quantitative real-t...
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome
-
- Bergqvist, Jenny (författare)
- Karolinska Institutet
-
Ohd, J. F. (författare)
-
- Smeds, J. (författare)
- Karolinska Institutet
-
visa fler...
-
Klaar, Sigrid (författare)
-
Isola, J. (författare)
-
- Nordgren, Hans (författare)
- Uppsala universitet,Institutionen för patologi
-
Elmberger, G. P. (författare)
-
Hellborg, H. (författare)
-
- Bjohle, J. (författare)
- Karolinska Institutet
-
Borg, A-L. (författare)
-
- Skoog, L. (författare)
- Karolinska Institutet
-
- Bergh, J. (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2007
- 2007
- Engelska.
-
Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 18:5, s. 845-850
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Our aim was to use quantitative real-time PCR (Q-PCR) and RNA expression profiles (RNA-EPs) to investigate HER2 status in relation to outcome. PATIENTS AND METHODS: Cut-off levels for Q-PCR and RNA-EP were established in relation to immunohistochemistry (IHC) validated by FISH in a test set of frozen tissue samples from 40 primary breast cancers. The HER2 status was subsequently studied in another validation set of 306 tumors, where Q-PCR and RNA-EP results were compared with previously carried out IHC that we had validated by chromogenic in situ hybridization (CISH). RESULTS: Q-PCR and RNA-EP offered similar sensitivity (90% versus 77%), specificity (93% versus 95%), and negative (99% versus 98%) and positive (63% versus 61%) predictive values for HER2 determinations. Analyses of relapse-free survival (RFS) and overall survival on the basis of 5 and 10 years of follow-up indicated equivalent hazard ratios for all three techniques. In contrast to IHC/CISH, both Q-PCR and RNA-EP analyses of HER2 also gave statistically significant results regarding RFS and breast cancer-corrected survival after 10 years of follow-up. CONCLUSION: The use of RNA-EP and Q-PCR to analyze HER2 in frozen and formalin-fixed breast cancer samples may be an alternate approach to IHC in combination with FISH/CISH.
Nyckelord
- breast cancer
- CISH
- diagnostic methods
- HER2
- quantitative real-time PCR
- RNA expression profiles
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bergqvist, Jenny
-
Ohd, J. F.
-
Smeds, J.
-
Klaar, Sigrid
-
Isola, J.
-
Nordgren, Hans
-
visa fler...
-
Elmberger, G. P.
-
Hellborg, H.
-
Bjohle, J.
-
Borg, A-L.
-
Skoog, L.
-
Bergh, J.
-
visa färre...
- Artiklar i publikationen
-
Annals of Oncolo ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet